LA times published an article called “New Drugs Boost health” by Thomas H. Maugh II, stating scientists have developed a newer, more effective class of AI’s. “One of the new drugs” Letrozole, sold under the brand name Femara by Novartis Inc, reduced the recurrence of breast cancer by 43% over current AI’s.
In the sudy producing these new AI’s, circulating levels of estogen was reduced by 95%.